NCT06983210 2025-08-14
GRAPE
Nagoya University
Phase 2 Recruiting
Clinical Trials
4 trialsNCT05064618 2024-04-04
MIKE-1
Nagoya University
Phase 1/2 Recruiting
NCT06085638 2024-03-07
Phase I/II Study of SY-1425 (Tamibarotene) in Combination With Azacitidine and Venetoclax for Patients With Chronic Myelomonocytic Leukemia
M.D. Anderson Cancer Center
Phase 1/2 Withdrawn
NCT00985530 2013-10-30
Tamibarotene and Arsenic Trioxide for Relapsed Acute Promyelocytic Leukemia
Northwestern University
Phase 1 Terminated